Provectus Biopharmaceuticals, Inc.

Historical 13F Holders

Symbol
PVCT
CUSIP
74373P108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 74373P108 since 12/18/2024, largest first.

Filer % of Class Filed
Pershing Edward 13D/A 11.6% 7/22/2026
Event 6/30/2026
Dominic Rodrigues 13D 5.7% 12/8/2025
Event 12/2/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 2 110 k $6.28k
2026 Q2 4 130 k $8.97k
2026 Q1 6 202 k $10.4k
2025 Q4 5 183 k $10.2k
2025 Q3 7 229 k $20.4k
2025 Q2 7 229 k $17.1k
2025 Q1 7 229 k $22.9k
2024 Q4 6 177 k $21.2k
2024 Q3 7 227 k $22.3k
2024 Q2 7 255 k $32.0k
2024 Q1 6 179 k $32.7k
2023 Q4 7 229 k $21.9k
2023 Q3 6 219 k $18.2k
2023 Q2 7 226 k $26.0k
2023 Q1 7 226 k $36.8k
2022 Q4 7 226 k $24.2k
2022 Q3 7 257 k $12.0k
2022 Q2 7 292 k $17.0k
2022 Q1 7 2.62 M $176k
2021 Q4 7 2.64 M $146k
2021 Q3 8 259 k $16.0k
2021 Q2 7 237 k $16.0k
2021 Q1 8 247 k $16.0k
2020 Q4 6 218 k $13.0k
2020 Q3 5 196 k $16.0k
2020 Q2 5 198 k $8.00k
2020 Q1 3 120 k $6.00k
2019 Q4 3 120 k $7.00k
2019 Q3 4 131 k $9.00k
2019 Q2 4 131 k $8.00k
2019 Q1 4 153 k $9.00k
2018 Q4 5 171 k $9.00k
2018 Q3 6 199 k $14.0k
2018 Q2 3 151 k $11.0k
2018 Q1 4 169 k $10.0k
2017 Q4 4 169 k $13.0k
2017 Q3 2 120 k $3.00k
2017 Q2 3 117 k $3.00k
2017 Q1 3 117 k $5.00k
2016 Q4 8 211 k $4.00k
2016 Q3 41 10.6 M $1.05M
2016 Q2 45 8.48 M $3.13M
2016 Q1 44 9.01 M $3.41M
2015 Q4 44 9.82 M $3.83M
2015 Q3 39 10.7 M $6.13M
2015 Q2 36 12.6 M $6.64M
2015 Q1 35 4.23 M $3.45M
2014 Q4 39 4.90 M $3.92M
2014 Q3 30 4.15 M $4.22M
2014 Q2 28 1.27 M $1.10M
2014 Q1 4 75.0 k $185k